US 8,575,108 B2Granted

Cyclosporin compositions

AssigneeAllergan, Inc.

InventorsJames N. Chang, Orest Olejnik, Bruce A. Firestone

Life of this patent

Estimating the term…

Abstract

A composition comprising from about 0.001% to about 0.4% cyclosporin A, a surfactant, and an oil having a specific gravity from 0.8 to 0.95 is disclosed herein.

Claims1

Dependent claims

A composition consisting essentially of from about 0.001% to about 0.05% cyclosporine A, Polysorbate, Pemulen, hydroxypropylmethyl cellulose, polyethylene glycol, and a carbomer, wherein said composition is an ophthalmically acceptable emulsion.

Dependencies are inferred from the claim text.

Facts

Application: 11/940,652Filed 15 Nov 2007 · continuation
Priority: 13 Jul 2005
Published: US 2008/0070834 A120 Mar 2008
Granted: 5 Nov 2013
Term ends: Not estimatedThe source records don’t support an estimate.

Classification7 codes

A61K 47/44
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents…: oils,…
A61K 9/0048
Galenical forms characterised by the site of application: eye, e.g. artificial tears
A61K 9/107
Dispersions; Emulsions: emulsions ; Emulsion preconcentrates; Micelles
A61K 38/13
Cyclic peptides , e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C: cyclosporins

Family

Application11/181,178Parent of this continuation · filed 13 Jul 2005
US 2008/0070834 A1Pre-grant publication · published 20 Mar 2008
US 7,297,679 B2Parent of this continuation
US 2007/0015690 A1Published application
US 8,575,108 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

Back to results